Evidence map›Paper›PMID 33207321›Full record

ArticlePhysics in medicine and biology2021

ROAD: ROtational direct Aperture optimization with a Decoupled ring-collimator for FLASH radiotherapy.

Qihui Lyu, Ryan Neph, Daniel O'Connor, Dan Ruan, Salime Boucher, Ke Sheng

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Transformative Technology for FLASH Radiation Therapy.Applied sciences (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Development of Ultra-High Dose-Rate (FLASH) Particle Therapy.IEEE transactions on radiation and plasma medical sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qihui LyuDepartment of Radiation Oncology, University of California Los Angeles, Los Angeles, CA 90095, United States of America.ORCID 0000-0002-1835-3870
Ryan NephDepartment of Radiation Oncology, University of California Los Angeles, Los Angeles, CA 90095, United States of America.ORCID 0000-0002-8176-6723
Daniel O'ConnorDepartment of Mathematics and Statistics, University of San Francisco, San Francisco, CA 94143, United States of America.ORCID 0000-0001-7378-1125
Dan RuanDepartment of Radiation Oncology, University of California Los Angeles, Los Angeles, CA 90095, United States of America.ORCID 0000-0003-3400-7684
Salime BoucherRadiaBeam Technologies, Santa Monica, CA 90404, United States of America.
Ke ShengDepartment of Radiation Oncology, University of California Los Angeles, Los Angeles, CA 90095, United States of America.

Funding

Development of a versatile robotic radiation therapy systemR44CA183390 · NCI · RADIABEAM TECHNOLOGIES, LLC · PI SHENG, KE, YONEMOTO, JAY · 2017 to 2024
$5.8M
Development of an ultra-high dose rate rotational linac for FLASH RadiotherapyR01CA255432 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGUSTSSON, RONALD, SHENG, KE · 2021 to 2025
$3.2M
Robust IMPT with automated beam orientation and scanning spot optimizationR01CA230278 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHENG, KE · 2019 to 2023
$1.9M
Motion Management of Pancreatic Cancer in MRI-Guided RadiotherapyR01CA188300 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHENG, KE · 2015 to 2019
$1.7M
(NCI) Developing an Intermediate Energy Linac for Robotic RadiotherapyR43CA183390 · NCI · RADIABEAM TECHNOLOGIES, LLC · PI BOUCHER, SALIME · 2015 to 2016
$265k
NCI NIH HHS R01 CA188300NCI NIH HHS R01 CA230278NCI NIH HHS R01 CA255432NCI NIH HHS R43 CA183390NCI NIH HHS R44 CA183390
6 · The paper itself

Abstract

Ultra-high dose rate in radiotherapy (FLASH) has been shown to increase the therapeutic index with markedly reduced normal tissue toxicity and the same or better tumor cell killing. The challenge to achieve FLASH using x-rays, besides developing a high output linac, is to intensity-modulate the high-dose-rate x-rays so that the biological gain is not offset by the lack of physical dose conformity. In this study, we develop the ROtational direct Aperture optimization with a Decoupled ring-collimator (ROAD) to achieve simultaneous ultrafast delivery and complex dose modulation. The ROAD design includes a fast-rotating slip-ring linac and a decoupled collimator-ring with 75 pre-shaped multi-leaf-collimator (MLC) modules. The ring-source rotates at 1 rotation per second (rps) clockwise while the ring-collimator is either static or rotating at 1 rps counterclockwise, achieving 75 (ROAD-75) or 150 (ROAD-150) equal-angular beams for one full arc. The Direct Aperture Optimization (DAO) for ROAD was formulated to include a least-square dose fidelity, an anisotropic total variation term, and a single segment term. The FLASH dose (FD) and FLASH biological equivalent dose (FBED) were computed voxelwise, with the latter using a spatiotemporal model accounting for radiolytic oxygen depletion. ROAD was compared with clinical volumetric modulated arc therapy (VMAT) on a brain, a lung, a prostate, and a head and neck cancer patient. The mean dose rate of ROAD-75 and ROAD-150 are 76.2 Gy s

Indexed as

GlioblastomaHead and Neck NeoplasmsHumansLung NeoplasmsMaleParticle AcceleratorsProstatic NeoplasmsRadiation Equipment and SuppliesRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-Assisted

Identifiers

PMID33207321
PMCPMC8683603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.